Purchase Order 75N92025P00313

Award Date 8/12/25
Potential Completion Date 9/26/25
Potential Value $14K
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Santa Clara, CA 95054, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Department of Health and Human Services National Institutes of Health National Heart Lung and Blood Institute awarded a $225,000.00 firm fixed price purchase order contract to Abbott Laboratories Inc., through its Abbott Vascular Inc. division, for a High-Density Cardiac Mapping Platform. The contract is for the delivery of this cardiovascular mapping system to support the agency's medical research mission. No set-aside designation was used. Abbott Laboratories is a large pharmaceutical...
This federal contract award, valued at $8,428.00, was issued by the Defense Logistics Agency (DLA) to Abbott Laboratories Inc. through its Abbott Vascular Inc. division. The contract is a Delivery Order for the provision of cardiovascular medical devices, including stents, pacemakers, heart valves, implantable cardiac monitors, mapping systems, and specialized surgical implants. The contract has a Fixed Price with Economic Price Adjustment pricing type and an ultimate completion date of December...
This federal contract award, valued at $33,700.00, was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Abbott Laboratories Inc. through its Abbott Vascular Inc. division. The contract is a fixed-price delivery order for the delivery of cardiovascular medical devices, including stents, pacemakers, heart valves, implantable cardiac monitors, mapping systems, and specialized surgical implants. The contract has an ultimate completion date of April 15, 2025....
This federal contract award, valued at $21,147.00, was issued by the Department of Defense's Medical Supply Chain agency to Abbott Laboratories Inc.'s Abbott Vascular Inc. division. The contract is a fixed-price delivery order with economic price adjustment, with a completion date of December 3, 2024. The award covers the provision of cardiovascular medical devices, including stents, pacemakers, heart valves, implantable cardiac monitors, mapping systems, and specialized surgical implants....
This federal contract award, valued at $21,425.00, was issued by the Defense Logistics Agency to the prime contractor Abbott Laboratories Inc. through its Abbott Vascular Inc. division. The contract is a Delivery Order for the delivery of cardiovascular medical devices, including stents, pacemakers, heart valves, implantable cardiac monitors, mapping systems, and specialized surgical implants. The contract has a fixed price with economic price adjustment pricing type and an ultimate completion...
This federal contract award, valued at $5,695.00, was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Abbott Laboratories Inc. through its Abbott Vascular Inc. division. The contract is a delivery order for the delivery of cardiovascular medical devices, including stents, pacemakers, heart valves, implantable cardiac monitors, mapping systems, and specialized surgical implants. The contract has a fixed price with economic price adjustment pricing type and...
This federal contract award, valued at $9,458.00, was issued by the Defense Logistics Agency to Abbott Laboratories Inc. through its Abbott Vascular Inc. division. The contract is a fixed-price delivery order with economic price adjustment, with a final completion date of November 25, 2024. The contract is for the supply of cardiovascular medical devices, including stents, pacemakers, heart valves, implantable cardiac monitors, mapping systems, and specialized surgical implants. Abbott...
This federal contract award, valued at $30,281.95, was issued by the Medical Supply Chain division of the Defense agency to Abbott Laboratories Inc. through its Abbott Vascular Inc. division. The contract is a fixed-price delivery order with economic price adjustment for the provision of cardiovascular medical devices, including stents, pacemakers, heart valves, implantable cardiac monitors, mapping systems, and specialized surgical implants. The contract does not have a set-aside designation,...
This federal contract award, valued at $8,108.00, was issued by the Defense Logistics Agency (DLA) to Abbott Laboratories Inc. through its Abbott Vascular Inc. division. The contract is for the delivery of cardiovascular medical devices, including stents, pacemakers, heart valves, implantable cardiac monitors, mapping systems, and specialized surgical implants. This is a fixed-price delivery order contract with an economic price adjustment, with a completion date of December 5, 2024. The...
This federal contract award, valued at $8,108.00, was issued by the Defense Logistics Agency (DLA) to Abbott Laboratories Inc. through its Abbott Vascular Inc. division. The contract is a fixed-price delivery order for the procurement of cardiovascular medical devices, including stents, pacemakers, heart valves, implantable cardiac monitors, mapping systems, and specialized surgical implants. The award does not include any set-aside designation, indicating full and open competition. Abbott...

This federal contract award is for the procurement of PCI aid devices, specifically Xience Skypoint stents from Abbott Laboratories Inc., for the Cardiac Cath Lab (Lederman Lab) of the National Heart Lung and Blood Institute (NHLBI), a civilian agency. The $13,650.00 firm fixed-price purchase order is to replace used and expired clinical inventory, with a completion date of September 26, 2025. The contract was awarded on August 12, 2025 without any set-aside designation, indicating full and open competition. Abbott Laboratories Inc., through its Abbott Vascular Inc. division, is the prime contractor for this award. The NHLBI, which is part of the National Institutes of Health, is the funding agency for this procurement. As a global healthcare company, Abbott Laboratories is a significant supplier of advanced cardiovascular medical technologies to various federal healthcare systems, including the Department of Veterans Affairs and the Defense Logistics Agency.

Generated 8/15/25, 9:53 AM